株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

子宮内膜症:世界の臨床試験レビュー

Endometriosis Global Clinical Trials Review, H2, 2016

発行 GlobalData 商品コード 212849
出版日 ページ情報 英文 172 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。

2016年12月31日まで 年末キャンペーン割引: GlobalData社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
子宮内膜症:世界の臨床試験レビュー Endometriosis Global Clinical Trials Review, H2, 2016
出版日: 2016年09月28日 ページ情報: 英文 172 Pages
概要

当レポートでは、子宮内膜症治療薬の臨床試験におけるデータを提供し、 国別の動向、臨床試験数、世界における臨床試験所別の募集状況などをまとめ、 概略以下の構成でお届けします。

目次

  • イントロダクション
    • 子宮内膜症
    • レポートガイダンス
  • 臨床試験 領域別
  • 臨床試験 国別
    • 臨床試験に寄与している上位5ヵ国 − アジア太平洋地域
    • 臨床試験に寄与している上位5ヵ国 − 欧州
    • 臨床試験に寄与している上位国 − 北米
    • 臨床試験に寄与している上位国 − 中東およびアフリカ
    • 臨床試験に寄与している上位国 − 中南米
  • 臨床試験:BRIC 諸国
  • 臨床試験:G7 諸国
  • 臨床試験:G7 諸国 治験ステータス別
  • 臨床試験:E7 諸国
  • 臨床試験:E7 諸国 治験ステータス別
  • 臨床試験 相別
    • 進行中の治験 相別
  • 臨床試験 治験ステータス別
  • 未完了の治験
  • 期間ごとの被験者数
  • 有力なスポンサー
    • 主な治験参加企業
  • 有望な治療薬比較
  • 臨床試験 プロファイル
    • 臨床試験概要: 上位企業
      • Abbott Laboratories
      • Bayer AG
      • Pfizer Inc.
      • Neurocrine Biosciences, Inc.
      • Repros Therapeutics Inc.
      • Novartis AG
      • AstraZeneca PLC
      • AEterna Zentaris Inc.
      • Ipsen Inc
      • Colorado Center for Reproductive Medicine
      • Isifer AB
      • Center for Human Reproduction
      • Tenon Hospital, Paris
      • Teva Pharmaceutical Industries Limited
      • KV Pharmaceutical Company
      • キッセイ薬品工業
      • Omrix Biopharmaceuticals, Inc.
    • 臨床試験概要: トップレベルの大学 / 研究機関 / 病院
      • University Hospital Gasthuisberg
      • Hospital Clinic de Barcelona
      • Katholieke Universiteit
      • Memorial University of Newfoundland
      • The University of South Florida
      • Taipei Veterans General Hospital
      • Zhejiang University
      • Huazhong University of Science & Technology
      • University of Western Sydney
      • Children's Hospital Boston
      • The University of North Carolina
      • Medical University of South Carolina
      • Samsung Medical Center
      • Rouen University Hospital
      • Sheba Medical Center
      • Dana-Farber Cancer Institute
      • University of Washington
      • Rigshospitalet
      • University of Pennsylvania
      • University of Oklahoma
  • 主要な臨床プロファイル

付録

図表一覧


このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC3741CTIDB

GlobalData's clinical trial report, "Endometriosis Global Clinical Trials Review, H2, 2016" provides an overview of Endometriosis clinical trials scenario. This report provides top line data relating to the clinical trials on Endometriosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Endometriosis to Women's Health Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Endometriosis to Women's Health Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Endometriosis Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Endometriosis
      • Sep 07, 2016: Repros Provides Phase 2 Results Showing Positive Outcomes for Oral Proellex in Women With Moderate to Severe Endometriosis
      • Jul 06, 2016: ObsEva Receives Clearance from US FDA to Initiate Phase 2b Study EDELWEISS with OBE2109, a Potentially Best-in-Class Oral GnRH Antagonist, for the Treatment of Endometriosis
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Endometriosis Therapeutics, Global, Clinical Trials by Region, 2016*
  • Endometriosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Endometriosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Endometriosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016*
  • Endometriosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Endometriosis Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Endometriosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016*
  • Endometriosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2016*
  • Proportion of Endometriosis to Women's Health Clinical Trials, G7 Countries (%), 2016*
  • Endometriosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Endometriosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Endometriosis to Women's Health Clinical Trials, E7 Countries (%), 2016*
  • Endometriosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Endometriosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Endometriosis Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Endometriosis Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Endometriosis Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Endometriosis Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Endometriosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Endometriosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Endometriosis Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Endometriosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Endometriosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Endometriosis Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Endometriosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Endometriosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Endometriosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016*
  • Endometriosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Endometriosis Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Endometriosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016*
  • Endometriosis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016*
  • Proportion of Endometriosis to Women's Health Clinical Trials, G7 Countries (%), 2016*
  • Endometriosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Endometriosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Endometriosis to Women's Health Clinical Trials, E7 Countries (%), 2016*
  • Endometriosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Endometriosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Endometriosis Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Endometriosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Endometriosis Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Endometriosis Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Endometriosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Endometriosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Endometriosis Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Endometriosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Endometriosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top